United States Anti-malarial Drugs Market Report 2017

Name: United States Anti-malarial Drugs Market Report 2017
Brand: QYResearch
SKU: UDB08163B47EN
Price: 3800 USD
Availability: InStock

September 2017 | 95 pages | ID: UDB08163B47EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Anti-malarial Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anti-malarial Drugs in these regions, from 2012 to 2022 (forecast).

United States Anti-malarial Drugs market competition by top manufacturers/players, with Anti-malarial Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Merck KGaA
F. Hoffmann-La Roche AG
Novartis AG
GlaxoSmithKline Plc
Ranbaxy Laboratories
Zydus Cadila
Alvizia Health Care
Bayer AG
Pfizer, Inc.
Ipca Laboratories Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Quinine
Chloroquine
Pyrimethamine
Amodiaquine
Proguanil
Mefloquine
Sulfonamide
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-malarial Drugs for each application, including

Falciparum Malaria
Vivax Malaria
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Anti-malarial Drugs Market Report 2017

1 ANTI-MALARIAL DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-malarial Drugs
1.2 Classification of Anti-malarial Drugs by Product Category
  1.2.1 United States Anti-malarial Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anti-malarial Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Quinine
  1.2.4 Chloroquine
  1.2.5 Pyrimethamine
  1.2.6 Amodiaquine
  1.2.7 Proguanil
  1.2.8 Mefloquine
  1.2.9 Sulfonamide
  1.2.10 Other
1.3 United States Anti-malarial Drugs Market by Application/End Users
  1.3.1 United States Anti-malarial Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Falciparum Malaria
  1.3.3 Vivax Malaria
  1.3.4 Others
1.4 United States Anti-malarial Drugs Market by Region
  1.4.1 United States Anti-malarial Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anti-malarial Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Anti-malarial Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anti-malarial Drugs Status and Prospect (2012-2022)
  1.4.5 New England Anti-malarial Drugs Status and Prospect (2012-2022)
  1.4.6 The South Anti-malarial Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Anti-malarial Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anti-malarial Drugs (2012-2022)
  1.5.1 United States Anti-malarial Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Anti-malarial Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTI-MALARIAL DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anti-malarial Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anti-malarial Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anti-malarial Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Anti-malarial Drugs Market Competitive Situation and Trends
  2.4.1 United States Anti-malarial Drugs Market Concentration Rate
  2.4.2 United States Anti-malarial Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anti-malarial Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTI-MALARIAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anti-malarial Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Anti-malarial Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Anti-malarial Drugs Price by Region (2012-2017)

4 UNITED STATES ANTI-MALARIAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anti-malarial Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anti-malarial Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-malarial Drugs Price by Type (2012-2017)
4.4 United States Anti-malarial Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTI-MALARIAL DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anti-malarial Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Anti-malarial Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTI-MALARIAL DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck KGaA
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-malarial Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck KGaA Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche AG
  6.2.2 Anti-malarial Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche AG Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis AG
  6.3.2 Anti-malarial Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis AG Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline Plc
  6.4.2 Anti-malarial Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Plc Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Ranbaxy Laboratories
  6.5.2 Anti-malarial Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ranbaxy Laboratories Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Zydus Cadila
  6.6.2 Anti-malarial Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Zydus Cadila Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Alvizia Health Care
  6.7.2 Anti-malarial Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Alvizia Health Care Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer AG
  6.8.2 Anti-malarial Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer AG Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Pfizer, Inc.
  6.9.2 Anti-malarial Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Pfizer, Inc. Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Ipca Laboratories Ltd
  6.10.2 Anti-malarial Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Ipca Laboratories Ltd Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANTI-MALARIAL DRUGS MANUFACTURING COST ANALYSIS

7.1 Anti-malarial Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-malarial Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti-malarial Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-malarial Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTI-MALARIAL DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anti-malarial Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anti-malarial Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Anti-malarial Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Anti-malarial Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-malarial Drugs
Figure United States Anti-malarial Drugs Market Size (MT) by Type (2012-2022)
Figure United States Anti-malarial Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Quinine Product Picture
Figure Chloroquine Product Picture
Figure Pyrimethamine Product Picture
Figure Amodiaquine Product Picture
Figure Proguanil Product Picture
Figure Mefloquine Product Picture
Figure Sulfonamide Product Picture
Figure Other Product Picture
Figure United States Anti-malarial Drugs Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Anti-malarial Drugs by Application in 2016
Figure Falciparum Malaria Examples
Table Key Downstream Customer in Falciparum Malaria
Figure Vivax Malaria Examples
Table Key Downstream Customer in Vivax Malaria
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Anti-malarial Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2022)
Figure United States Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-malarial Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Anti-malarial Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Anti-malarial Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-malarial Drugs Sales Share by Players/Suppliers
Figure 2017 United States Anti-malarial Drugs Sales Share by Players/Suppliers
Figure United States Anti-malarial Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anti-malarial Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anti-malarial Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-malarial Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Anti-malarial Drugs Revenue Share by Players/Suppliers
Table United States Market Anti-malarial Drugs Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Anti-malarial Drugs Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Anti-malarial Drugs Market Share of Top 3 Players/Suppliers
Figure United States Anti-malarial Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anti-malarial Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anti-malarial Drugs Product Category
Table United States Anti-malarial Drugs Sales (MT) by Region (2012-2017)
Table United States Anti-malarial Drugs Sales Share by Region (2012-2017)
Figure United States Anti-malarial Drugs Sales Share by Region (2012-2017)
Figure United States Anti-malarial Drugs Sales Market Share by Region in 2016
Table United States Anti-malarial Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anti-malarial Drugs Revenue Share by Region (2012-2017)
Figure United States Anti-malarial Drugs Revenue Market Share by Region (2012-2017)
Figure United States Anti-malarial Drugs Revenue Market Share by Region in 2016
Table United States Anti-malarial Drugs Price (USD/Kg) by Region (2012-2017)
Table United States Anti-malarial Drugs Sales (MT) by Type (2012-2017)
Table United States Anti-malarial Drugs Sales Share by Type (2012-2017)
Figure United States Anti-malarial Drugs Sales Share by Type (2012-2017)
Figure United States Anti-malarial Drugs Sales Market Share by Type in 2016
Table United States Anti-malarial Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anti-malarial Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-malarial Drugs by Type (2012-2017)
Figure Revenue Market Share of Anti-malarial Drugs by Type in 2016
Table United States Anti-malarial Drugs Price (USD/Kg) by Types (2012-2017)
Figure United States Anti-malarial Drugs Sales Growth Rate by Type (2012-2017)
Table United States Anti-malarial Drugs Sales (MT) by Application (2012-2017)
Table United States Anti-malarial Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-malarial Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-malarial Drugs Sales Market Share by Application in 2016
Table United States Anti-malarial Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anti-malarial Drugs Sales Growth Rate by Application (2012-2017)
Table Merck KGaA Basic Information List
Table Merck KGaA Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck KGaA Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Merck KGaA Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Merck KGaA Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Ranbaxy Laboratories Basic Information List
Table Ranbaxy Laboratories Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ranbaxy Laboratories Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Ranbaxy Laboratories Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Ranbaxy Laboratories Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Zydus Cadila Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Zydus Cadila Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Zydus Cadila Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Alvizia Health Care Basic Information List
Table Alvizia Health Care Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Alvizia Health Care Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Alvizia Health Care Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Alvizia Health Care Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer AG Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Bayer AG Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Bayer AG Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Pfizer, Inc. Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer, Inc. Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Ipca Laboratories Ltd Basic Information List
Table Ipca Laboratories Ltd Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ipca Laboratories Ltd Anti-malarial Drugs Sales Growth Rate (2012-2017)
Figure Ipca Laboratories Ltd Anti-malarial Drugs Sales Market Share in United States (2012-2017)
Figure Ipca Laboratories Ltd Anti-malarial Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-malarial Drugs
Figure Manufacturing Process Analysis of Anti-malarial Drugs
Figure Anti-malarial Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-malarial Drugs Major Players/Suppliers in 2016
Table Major Buyers of Anti-malarial Drugs
Table Distributors/Traders List
Figure United States Anti-malarial Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Anti-malarial Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anti-malarial Drugs Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Anti-malarial Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Anti-malarial Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Anti-malarial Drugs Sales Volume (MT) Forecast by Type in 2022
Table United States Anti-malarial Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Anti-malarial Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Anti-malarial Drugs Sales Volume (MT) Forecast by Application in 2022
Table United States Anti-malarial Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Anti-malarial Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-malarial Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-malarial Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Anti-malarial Drugs Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports